Loading clinical trials...

Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT04047875

Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant

Long-acting reversible contraceptives \[LARC; copper-intrauterine devices (IUDs), the levonorgestrel-releasing intrauterine system (LNG-IUS) and subdermal implants\] are the most effective reversible ...

Lead sponsor: University of Sao Paulo•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDPhase 4

Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users

NCT04205929 · Bleeding, Implants, and more

COMPLETEDNA

Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases

NCT01469585 · Breakthrough Bleeding

COMPLETEDPhase 4

Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users

NCT02903121 · Bleeding, Implants, and more

COMPLETEDPhase 2

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

NCT00394771 · Breakthrough Bleeding

COMPLETEDNA

Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

NCT00475553 · Breakthrough Bleeding, Breakthrough Spotting

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 23, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment114

Start dateSep 2020

Last updatedSep 23, 2024

Condition

Breakthrough Bleeding

Locations shown

Unidade de Pesquisa Clínica do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto

Ribeirão Preto, São Paulo

UNIFESP

São Paulo, São Paulo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 23, 2024Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions